Cargando…

Blastocystosis in patients with gastrointestinal symptoms: a case–control study

BACKGROUND: Blastocystosis is a frequent bowel disease. We planned to to evaluate the prevalence of Blastocystis spp. in patients who applied to the same internal medicine-gastroenterology clinic with or without gastrointestinal complaints to reveal the association of this parasite with diagnosed IB...

Descripción completa

Detalles Bibliográficos
Autores principales: Cekin, Ayhan Hilmi, Cekin, Yesim, Adakan, Yesim, Tasdemir, Ezel, Koclar, Fatma Gulsun, Yolcular, Basak Oguz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444885/
https://www.ncbi.nlm.nih.gov/pubmed/22963003
http://dx.doi.org/10.1186/1471-230X-12-122
_version_ 1782243731338952704
author Cekin, Ayhan Hilmi
Cekin, Yesim
Adakan, Yesim
Tasdemir, Ezel
Koclar, Fatma Gulsun
Yolcular, Basak Oguz
author_facet Cekin, Ayhan Hilmi
Cekin, Yesim
Adakan, Yesim
Tasdemir, Ezel
Koclar, Fatma Gulsun
Yolcular, Basak Oguz
author_sort Cekin, Ayhan Hilmi
collection PubMed
description BACKGROUND: Blastocystosis is a frequent bowel disease. We planned to to evaluate the prevalence of Blastocystis spp. in patients who applied to the same internal medicine-gastroenterology clinic with or without gastrointestinal complaints to reveal the association of this parasite with diagnosed IBS and IBD. METHODS: A total of 2334 patients with gastrointestinal symptoms composed the study group, which included 335 patients with diagnosed inflammatory bowel disease and 877 with irritable bowel syndrome. Patients without any gastrointestinal symptoms or disease (n = 192) composed the control group. Parasite presence was investigated by applying native-Lugol and formol ethyl acetate concentration to stool specimens, and trichrome staining method in suspicious cases. RESULTS: Blastocystis spp. was detected in 134 patients (5.74%) in the study group and 6 (3.12%) in the control group (p = 0.128). In the study group, Blastocystis spp. was detected at frequencies of 8.7% in ulcerative colitis (24/276), 6.78% in Crohn’s disease (4/59), 5.82% in irritable bowel syndrome (51/877), and 4.9% in the remaining patients with gastrointestinal symptoms (55/1122). Blastocystis spp. was detected at a statistically significant ratio in the inflammatory bowel disease (odds ratio [OR] = 2.824; 95% confidence interval [CI]: 1.149-6.944; p = 0.019) and ulcerative colitis (OR = 2.952; 95% CI: 1.183-7.367; p = 0.016) patients within this group compared to controls. There were no statistically significant differences between the control group and Crohn’s disease or irritable bowel syndrome patients in terms Blastocystis spp. frequency (p = 0.251, p = 0.133). CONCLUSIONS: Blastocystosis was more frequent in patients with inflammatory bowel disease, especially those with ulcerative colitis. Although symptomatic irritable bowel syndrome and Crohn’s disease patients had higher rates of Blastocystis spp. infection, the differences were not significant when compared to controls.
format Online
Article
Text
id pubmed-3444885
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34448852012-09-19 Blastocystosis in patients with gastrointestinal symptoms: a case–control study Cekin, Ayhan Hilmi Cekin, Yesim Adakan, Yesim Tasdemir, Ezel Koclar, Fatma Gulsun Yolcular, Basak Oguz BMC Gastroenterol Research Article BACKGROUND: Blastocystosis is a frequent bowel disease. We planned to to evaluate the prevalence of Blastocystis spp. in patients who applied to the same internal medicine-gastroenterology clinic with or without gastrointestinal complaints to reveal the association of this parasite with diagnosed IBS and IBD. METHODS: A total of 2334 patients with gastrointestinal symptoms composed the study group, which included 335 patients with diagnosed inflammatory bowel disease and 877 with irritable bowel syndrome. Patients without any gastrointestinal symptoms or disease (n = 192) composed the control group. Parasite presence was investigated by applying native-Lugol and formol ethyl acetate concentration to stool specimens, and trichrome staining method in suspicious cases. RESULTS: Blastocystis spp. was detected in 134 patients (5.74%) in the study group and 6 (3.12%) in the control group (p = 0.128). In the study group, Blastocystis spp. was detected at frequencies of 8.7% in ulcerative colitis (24/276), 6.78% in Crohn’s disease (4/59), 5.82% in irritable bowel syndrome (51/877), and 4.9% in the remaining patients with gastrointestinal symptoms (55/1122). Blastocystis spp. was detected at a statistically significant ratio in the inflammatory bowel disease (odds ratio [OR] = 2.824; 95% confidence interval [CI]: 1.149-6.944; p = 0.019) and ulcerative colitis (OR = 2.952; 95% CI: 1.183-7.367; p = 0.016) patients within this group compared to controls. There were no statistically significant differences between the control group and Crohn’s disease or irritable bowel syndrome patients in terms Blastocystis spp. frequency (p = 0.251, p = 0.133). CONCLUSIONS: Blastocystosis was more frequent in patients with inflammatory bowel disease, especially those with ulcerative colitis. Although symptomatic irritable bowel syndrome and Crohn’s disease patients had higher rates of Blastocystis spp. infection, the differences were not significant when compared to controls. BioMed Central 2012-09-10 /pmc/articles/PMC3444885/ /pubmed/22963003 http://dx.doi.org/10.1186/1471-230X-12-122 Text en Copyright ©2012 Cekin et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Cekin, Ayhan Hilmi
Cekin, Yesim
Adakan, Yesim
Tasdemir, Ezel
Koclar, Fatma Gulsun
Yolcular, Basak Oguz
Blastocystosis in patients with gastrointestinal symptoms: a case–control study
title Blastocystosis in patients with gastrointestinal symptoms: a case–control study
title_full Blastocystosis in patients with gastrointestinal symptoms: a case–control study
title_fullStr Blastocystosis in patients with gastrointestinal symptoms: a case–control study
title_full_unstemmed Blastocystosis in patients with gastrointestinal symptoms: a case–control study
title_short Blastocystosis in patients with gastrointestinal symptoms: a case–control study
title_sort blastocystosis in patients with gastrointestinal symptoms: a case–control study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444885/
https://www.ncbi.nlm.nih.gov/pubmed/22963003
http://dx.doi.org/10.1186/1471-230X-12-122
work_keys_str_mv AT cekinayhanhilmi blastocystosisinpatientswithgastrointestinalsymptomsacasecontrolstudy
AT cekinyesim blastocystosisinpatientswithgastrointestinalsymptomsacasecontrolstudy
AT adakanyesim blastocystosisinpatientswithgastrointestinalsymptomsacasecontrolstudy
AT tasdemirezel blastocystosisinpatientswithgastrointestinalsymptomsacasecontrolstudy
AT koclarfatmagulsun blastocystosisinpatientswithgastrointestinalsymptomsacasecontrolstudy
AT yolcularbasakoguz blastocystosisinpatientswithgastrointestinalsymptomsacasecontrolstudy